Showing results (1291-1300 of 3,339) with videos related to

Sort By:
Pageof 334
Metabolic Brain Disease|August 12, 2008
Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in ratsGregory W Konat, Michal Kraszpulski, Isaac James, et al.
Metabolic Brain Disease|December 11, 2008
Interorgan ammonia trafficking in liver diseaseSteven W M Olde Damink, Rajiv Jalan, Cornelius H C Dejong
Metabolic Brain Disease|December 11, 2008
Neuropsychiatric disorders related to interferon and interleukins treatmentAye Mu Myint, Markus J Schwarz, Harry W M Steinbusch, et al.
Metabolic Brain Disease|March 1, 1991
Aflatoxin B1 alters central and systemic tryptophan and tyrosine metabolism: influence of immunomodulatory drugsL B Weekley
Metabolic Brain Disease|January 17, 2009
RNA oxidation and zinc in hepatic encephalopathy and hyperammonemiaFreimut Schliess, Boris Görg, Dieter Häussinger
Metabolic Brain Disease|October 7, 2008
The enhanced hyperglycemic response to hemorrhage hypotension in obese rats is related to an impaired baroreflexDaniel Carvalho de Lima, Simonton Andrade Silveira, Andréa Siqueira Haibara, et al.
Metabolic Brain Disease|January 9, 2009
Hepatitis C virus infection and the brainKarin Weissenborn, Anita B Tryc, Meike Heeren, et al.
Metabolic Brain Disease|August 8, 2008
Selective alterations of brain dopamine D(2) receptor binding in cirrhotic patients: results of a (11)C-N-methylspiperone PET studyYuki Watanabe, Akinobu Kato, Kei Sawara, et al.
Metabolic Brain Disease|November 21, 2007
Hexacosanoic and docosanoic acids plasma levels in patients with cerebral childhood and asymptomatic X-linked adrenoleukodystrophy: Lorenzo's oil effectMarion Deon, Mariana Pires Garcia, Angela Sitta, et al.
Metabolic Brain Disease|November 21, 2007
Oxidative stress in plasma from maple syrup urine disease patients during treatmentAlethéa G Barschak, Angela Sitta, Marion Deon, et al.
Pageof 334